| Stage | NVDA | % of rev | TXN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $6.1B | 100.00% | NVDA ×15.89 |
| Gross profit | $72.1B | 74.98% | $3.9B | 64.19% | NVDA +10.8pp |
| Operating income | $63.7B | 66.24% | $2.9B | 47.46% | NVDA +18.8pp |
| Pre-tax income | $71.5B | 74.32% | $2.8B | 46.33% | NVDA +28.0pp |
| Net income | $59.7B | 62.03% | $2.4B | 40.05% | NVDA +22.0pp |
| Stage | NVDA | TXN | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $6.1B100.00% | NVDA ×15.89 |
| Gross profit | 74.98%$72.1B | 64.19%$3.9B | NVDA +10.8pp |
| Operating income | 66.24%$63.7B | 47.46%$2.9B | NVDA +18.8pp |
| Pre-tax income | 74.32%$71.5B | 46.33%$2.8B | NVDA +28.0pp |
| Net income |
| 62.03%$59.7B |
| 40.05%$2.4B |
| NVDA +22.0pp |
No shared counterparties.